US › Healthcare

LifeMD Inc (LFMD)

US · Healthcare · Health Information Services

$3.20-0.31%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$47.3M

Revenue YoY

-24.0%

Net profit

$-7.1M

EPS

$-0.16

EPS estimate

$-0.20

Net margin

-15.0%

EPS came in at -0.16 against a street estimate of -0.20 — a beat of 20.0%.

Key statistics

Market cap

$163.9M

Forward P/E

12.9

P/B

20.81

Book value

$0.17

EPS (TTM)

$-0.52

52-week high

$7.32

52-week low

$2.56

50-day MA

$3.67

200-day MA

$3.83

Beta

2.04

Analyst view

Analysts rate LifeMD Inc a strong buy (7 buy, 1 hold, 0 sell out of 8) with an average price target of $8.12.

Shareholding

Insiders

14.69%

Institutions

45.02%

Largest institutional holders

Fund	Stake
BlackRock Inc	5.83%
Federated Hermes Inc	5.70%
Vanguard Capital Management, LLC	3.45%
Royce & Associates, LP	2.49%
Renaissance Technologies Corp	2.32%
State Street Corp	2.23%
Geode Capital Management, LLC	2.12%
Prescott Group Capital Management LLC	1.86%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for LifeMD Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.